PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Liraglutide - Weight management in adolescents
PAD Profile : Liraglutide - Weight management in adolescents
Keywords :
obesity, overweight, weight loss
Brand Names Include :
Saxenda
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
02 February 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands APC does not recommend the use of Liraglutide (Saxenda) for managing obesity in people aged 12 to 17 years.
This decision follows the termination of the NICE appraisal (TA749): Liraglutide for managing obesity in people aged 12 to 17 years.
Associated BNF Codes
06. Endocrine System
06.01.02. Antidiabetic drugs